913237-70-4

Upstream product

• 1663-39-4 tert-Butyl acrylate 
• 208036-26-4 (E)-t-butyl 4-formylcinnamate 

Downstream Products

• 1109237-01-5 C₂₁H₁₉N₃O₅ 
• 1109236-93-2 (E)-tert-butyl 3-(4-(aminomethyl)phenyl)acrylate hydrochloride 
• 1109237-13-9 C₂₂H₁₉N₃O₆ 
• 1109236-96-5 C₂₅H₂₇N₃O₅ 
• 1109236-72-7 C₂₁H₂₀N₄O₅ 
• 1109236-81-8 C₂₂H₂₀N₄O₆ 
• 1109237-11-7 C₂₆H₂₇N₃O₆ 
• 1109237-07-1 C₄₀H₃₄N₄O₅ 
• 1109237-15-1 C₄₁H₃₄N₄O₆ 

Relevant academic research and scientific papers

Dual inhibitors of inosine monophosphate dehydrogenase and histone deacetylase based on a cinnamic hydroxamic acid core structure

Small molecules that act on multiple biological targets have been proposed to combat the drug resistance commonly observed for cancer chemotherapy. By combining the structural features of known inhibitors of inosine monophosphate dehydrogense (IMPDH) and

ANTICANCER AGENTS

The invention provides a compound of the invention, which is a compound of formula A-X-L-B, or a salt thereof, as well as compositions comprising a compound of the invention, and therapeutic methods that include the administration of a compound of the inv